• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Atrial Fibrillation

WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device

by Fred Pennic 05/21/2024 Leave a Comment

WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA 510(k) Cleared 6-Lead ECG Device

What You Should Know:  - WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.  - The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.  Tackling the
Read More

GE Healthcare Launches Digital Tool for AFib

by Fred Pennic 08/25/2023 Leave a Comment

GE Healthcare Launches Digital Tool for AFib

What You Should Know: - GE HealthCare launches CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data relevant for disease progression from multiple data sources, and driving evidence based clinical decision support directed by up-to-date AFib guidelines. - CardioVisio for Atrial Fibrillation is now commercially available in the U.S. GE Healthcare plans to expand availability in the coming months incorporating
Read More

FDA Clears Samsung’s Irregular Heart Rhythm Notification

by Fred Pennic 05/08/2023 Leave a Comment

FDA Clears Samsung’s Irregular Heart Rhythm Notification

What You Should Know: Today, Samsung announced today its Irregular Heart Rhythm Notification feature of the Samsung Health Monitor App has been cleared by the FDA. With this new feature, Galaxy Watch users can be alerted when heart rhythms suggestive of atrial fibrillation (AFib) – a type of arrhythmia – are detected.The Irregular Heart Rhythm Notification works with the app’s existing on-demand Electrocardiogram function to proactively monitor heart rhythms suggestive of AFib, and
Read More

Veradigm and HealthVerity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes

by Jasmine Pennic 02/13/2023 Leave a Comment

Veradigm and HealthVerity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes

What You Should Know: - Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem. - The HealthVerity IPGE platform is an integrated technology and
Read More

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

by Fred Pennic 12/15/2022 Leave a Comment

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More

Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions

by Syed Hamza Sohail 12/06/2022 Leave a Comment

Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions

What You Should Know: - The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients. - This follows other recent research findings, published in The
Read More

KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022

by Syed Hamza Sohail 09/02/2022 Leave a Comment

KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022

What You Should Know: - A new report from KLAS focuses on healthcare-specific deployments of Microsoft Cloud Technologies, especially Microsoft Azure, which is receiving strong market interest. - This study is meant to help organizations considering Microsoft Cloud technologies understand their current use, the overall customer experience, and the impact of the solutions. Key Healthcare Trends in Microsoft Cloud Technologies in 2022 While still early, healthcare is gaining momentum
Read More

GE Healthcare Makes Strategic Investment in AliveCor

by Syed Hamza Sohail 08/17/2022 Leave a Comment

AliveCor Launches KardiaMobile Card, World’s First Credit-Card-Sized Personal ECG

What You Should Know: - AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare. - The round also included participation from Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners. Providing End-to-End Cardiological Care Using Subscription Services AliveCor, Inc. is transforming cardiological care using deep
Read More

FDA Awards 510(k) Clearances for ZEUS System/Zio Watch

by Fred Pennic 07/22/2022 Leave a Comment

iRhythm + Verily Awarded FDA Clearances on ZEUS System/Zio Watch

What You Should Know: - Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, prescription-based solution that will improve clinician workflows, care pathways and the patient experience.  - The ZEUS System is the AI algorithm and solution component of the Zio Watch – a clinical grade, long-term and noninvasive wearable that not only
Read More

Analysis: How Will The Roadmap for Diagnostic Cardiology Devices Develop?

by Kelly Patrick, Principal Analyst at Signify Research 06/30/2022 Leave a Comment

Analysis: How Will The Roadmap for Diagnostic Cardiology Devices Develop?

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |